🇺🇸 Mencevax in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 12

Most-reported reactions

1. Cardiac Arrest — 2 reports (16.67%)
2. Cardio-Respiratory Arrest — 2 reports (16.67%)
3. Acute Myeloid Leukaemia — 1 report (8.33%)
4. Bone Pain — 1 report (8.33%)
5. Bronchitis — 1 report (8.33%)
6. Cervical Dysplasia — 1 report (8.33%)
7. Chills — 1 report (8.33%)
8. Convulsion — 1 report (8.33%)
9. Drug Ineffective — 1 report (8.33%)
10. Drug Interaction — 1 report (8.33%)

Source database →

Frequently asked questions

Is Mencevax approved in United States?

Mencevax does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Mencevax in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.